Biomarker-driven molecular imaging probes in radiotherapy

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy

Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper